IRON (Disc Medicine, Inc.) Stock Financials & Earnings | Market Cap Arena

IRON (Disc Medicine, Inc.) Stock Financials & Earnings | Market Cap Arena

IRONDisc Medicine, Inc.

Mkt Cap$2B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$212M

EPS (TTM)-$6.01

Free Cash Flow (TTM)-$181M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$0	$0	-$25M
Q2 23	$0	$0	-$17M
Q3 23	$0	$0	-$19M
Q4 23	$0	$0	-$30M
Q1 24	$0	$0	-$31M
Q2 24	$0	$0	-$31M
Q3 24	$0	$0	-$33M
Q4 24	$0	-$9K	-$35M
Q1 25	$0	$0	-$40M
Q2 25	$0	$0	-$61M
Q3 25	$0	-$87K	-$68M
Q4 25	$0	-$89K	-$67M

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$35M	-$35M
Q2 23	-$13M	-$13M
Q3 23	-$7M	-$8M
Q4 23	-$18M	-$18M
Q1 24	-$34M	-$34M
Q2 24	-$15M	-$15M
Q3 24	-$17M	-$17M
Q4 24	-$28M	-$28M
Q1 25	-$41M	-$42M
Q2 25	-$48M	-$48M
Q3 25	-$48M	-$48M
Q4 25	-$43M	-$43M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$29K
Q2 23	$12K
Q3 23	$45K
Q4 23	$3K
Q1 24	$67K
Q2 24	$3K
Q3 24	$8K
Q4 24	$449K
Q1 25	$851K
Q2 25	$36K
Q3 25	$26K
Q4 25	$20K

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	—	+152.3%
Q2 23	—	+44.2%
Q3 23	—	+80.9%
Q4 23	—	+39.3%
Q1 24	—	+25.2%
Q2 24	—	+78.0%
Q3 24	—	+73.3%
Q4 24	—	+16.3%
Q1 25	—	+27.0%
Q2 25	—	+99.0%
Q3 25	—	+106.0%
Q4 25	—	+93.8%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$1M	—
Q2 23	$1M	—
Q3 23	$1M	—
Q4 23	$2M	—
Q1 24	$4M	—
Q2 24	$4M	—
Q3 24	$4M	—
Q4 24	$4M	—
Q1 25	$6M	—
Q2 25	$8M	—
Q3 25	$10M	—
Q4 25	$0	—

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q1 23	$20M	$5M	—
Q2 23	$12M	$5M	—
Q3 23	$14M	$5M	—
Q4 23	$23M	$7M	—
Q1 24	$24M	$8M	—
Q2 24	$23M	$7M	—
Q3 24	$25M	$8M	—
Q4 24	$25M	$10M	—
Q1 25	$28M	$12M	—
Q2 25	$46M	$15M	—
Q3 25	$50M	$17M	—
Q4 25	$46M	—	$21M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$236M	$0	$236M
Q2 23	$378M	$0	$378M
Q3 23	$371M	$0	$371M
Q4 23	$360M	$0	$360M
Q1 24	$343M	$0	$343M
Q2 24	$281M	$220M	$501M
Q3 24	$193M	$295M	$487M
Q4 24	$192M	$297M	$490M
Q1 25	$123M	$572M	$695M
Q2 25	$127M	$523M	$650M
Q3 25	$141M	$475M	$616M
Q4 25	$91M	$700M	$791M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	19M	+1795.7%
Q2 23	21M	+13.3%
Q3 23	24M	+13.2%
Q4 23	24M	-3.1%
Q1 24	25M	+5.3%
Q2 24	26M	+3.4%
Q3 24	30M	+16.7%
Q4 24	30M	+0.0%
Q1 25	33M	+11.3%
Q2 25	35M	+5.1%
Q3 25	35M	+0.4%
Q4 25	35M	+0.3%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 20	$0	29
FY 21	$0	33
FY 22	$0	46
FY 23	$0	74
FY 24	$0	84
FY 25	$0	100K